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Focal adhesion kinase (FAK) is a pivotal regulator of integrin signaling and responses to cell adhesive
dynamics. In this issue ofDevelopmental Cell, Ashton et al. demonstrate that Fak is critical for intestinal onco-
genesis and regeneration after injury but not for day-to-day homeostasis, providing novel insights into intes-
tinal biology and colorectal cancer therapy.Large, long-lived organisms like verte-
brates demand three things of their most
environmentally exposed tissues—that
they self-assemble reliably and consis-
tently during development, that theymain-
tain themselves homeostatically (at least
through reproductive life), and that they
repair themselves with adequate fidelity
if damaged or disrupted. Nonetheless,
unfettering the capacity of those same
tissues to regenerate must be tempered
by the risk of individual somatic cells
going rogue and expanding into life-
threatening tumors. The resultingcompro-
mise entails a complicated and dynamic
balancing act between social control and
individual liberty that would make the
authors of the U.S. Constitution blushwith
humility. Tomakemattersworse,dramatic
differences in architecture, turnover, and
risk of neoplasia, damage, and infection
among differing tissues mean that the
rules governing homeostasis and repair
must vary greatly between tissue types,
raising the fascinating question of how
evolution has managed to balance such
diverse dynamics in so many different
tissue types using only a limited, common
toolkit of signaling and effectormolecules.
In this regard, intestinal epithelium is an
especially informative adult tissue for
study. Its distinctive epithelial architec-
ture, supporting the continuous and swift
conveyer belt that shuttles newborn
cells out of the crypt to their demise at
the villus tip provides, at once, both
a spatial and temporal map of the tissue’s
dynamics and an unparalleled opportunity
to establish cause-and-effect relation-
ships between underlying signaling path-
waysandconsequent biology—especially
when, as in the accompanying paper in
this issue ofDevelopmental Cellby Ashton
et al. (2010), combined with state-of-the-
art switchable mouse genetics.The Wnt/b-catenin and Notch path-
ways together govern the development,
maintenance and repair of the intestinal
epithelium. However, the Wnt/b-catenin
axis is pre-eminent in maintaining the
proliferation of both the crypt stem cell
and adjacent transit amplifying compart-
ments, acting in great part through the
proto-oncogene c-myc (He et al., 1998).
It is also essential for the appropriate
spatial disposition of the different cell
types that comprise the crypt-villus unit
and for migration of epithelial cells up
the crypt-villus axis (Batlle et al., 2002).
Constitutive signaling through the Wnt/
b-catenin/TCF pathway effectively locks
intestinal cells in a crypt progenitor-like
state and drives the precocious prolifera-
tion and suppressed differentiation that
underpins most colorectal cancers (van
de Wetering et al., 2002).
Ashton et al. (2010) focus their attention
on the potential role in intestinal homeo-
stasis and regeneration played by focal
adhesion kinase (FAK), the integrin-acti-
vated cytoplasmic tyrosine kinase that
articulates the highly nuanced responses
of epithelial and other cell types to
changes in intercellular adhesion status.
Although there is as yet no definitive
evidence linking FAK kinase activity with
tumorigenesis, FAK is upregulated in colo-
rectal cancers from its earliest stages
and its role in integrin signaling places it
center stage in many processes that drive
colorectal cancer—cell adhesion, prolifer-
ation, invasion, migration, and survival.
Conversely, little is known of the role FAK
plays in normal, adult intestinal biology.
Ashton et al. (2010) use conditional,
intestine-specific deletion of FAK and its
upstream and downstream signaling part-
ners to define the role of FAK signaling in
intestinal homeostasis and regeneration.
The first surprise is that FAK is dispens-Developmental Cell 19able for quotidian intestinal homeo-
stasis—quite unlike the Wnt/b-catenin
target gene c-myc, whose ablation pre-
cipitates immediate failure of intestinal
crypt maintenance (Muncan et al., 2006;
Soucek et al., 2008). Of note, a major limi-
tation of conditional cre-lox technology is
that gene deletion is never quantitative
throughout a tissue—unrecombined cells
always remain. In the case of c-myc dele-
tion, such residual c-myc competent cells
rapidly outgrow those crypts deficient in
c-myc, presently obscuring the c-myc
deletion phenotype (Bettess et al., 2005;
Muncan et al., 2006) and confirming the
critical role c-myc plays in crypt-villus
homeostasis. No analogous outgrowth
of FAK-competent crypts occurs after
conditional deletion of FAK, belying even
the most subtle of homeostatic roles for
FAK.
The situation is, however, quite different
during intestinal regeneration after injury.
Intestinal epithelium is prey to damage
and disruption by pathogens, parasites,
injury, and immune attack but must
nonetheless steadfastly maintain its crit-
ical barrier and absorptive functions.
Consequently, intestinal epitheliumenjoys
significant regenerative capacity. When
intestinal regeneration is experimentally
triggered by radiation injury, FAK is
induced. Likewise, superactivation of
the Wnt/b-catenin pathway through acute
ablation of theApc gene upregulates FAK.
Moreover, induction of FAK by either radi-
ation injury or elevated Wnt/b-catenin
signaling is abrogated upon deletion of
c-myc, consistent with the notion that
FAK expression is induced by a Wnt/
b-catenin/c-myc pathway. However, this
doesn’t actually prove that c-Myc is the
bona fide downstream Wnt/b-catenin
effector that transcriptionally elicits FAK
expression because basal c-myc activity, August 17, 2010 ª2010 Elsevier Inc. 185
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Previewsmight instead be serving as a permissivity
factor that renders the FAK gene compe-
tent for induction by some other Wnt/
b-catenin-induced transcription factor.
Ashton et al. (2010) elegantly refute this
latter possibility by showing that constitu-
tive expression of c-myc at physiological
levels, in this case from the weak but
Wnt/b-catenin-insensitive Rosa26 pro-
moter (Murphy et al., 2008), cannot
compensate for deletion of the endoge-
nous c-mycgene.Hence, c-mycmediates
intestinal regeneration and FAK upregula-
tion only if it is responsive to Wnt/b-cate-
nin signaling. Case closed. As icing on
the cake, they also show that FAK function
is required for overt intestinal tumorigen-
esis induced in vivo by inactivation of
Apc. Given that FAK loss has no discern-
ible impact on intestinal homeostasis,
this opens the way for both prophylactic
and therapeutic use of FAK inhibitors in
colorectal cancer. Indeed, the pivotal
role played by FAK in both regenerative
and oncogenic Wnt/b-catenin-induced
intestinal regeneration, but not in intestinal
homeostasis, is especially provocative:
it indicates the existence of a discrete,
evolved, intestinal regenerative program
distinct from normal intestinal homeo-
stasis and, in turn, implies that colorectal
oncogenesis is a hijacked version of this
dedicated regenerative program.
FAK is implicated in many biological
functions, most notably resistance to
detachment-induced cell death (anoikis)
and, ipso facto, tumor invasion and
metastasis. But what might FAK do to186 Developmental Cell 19, August 17, 2010support intestinal regeneration? Here,
the situation is more murky. Ashton et al.
(2010) show that FAK status has no effect
on the immediate induction of intestinal
apoptosis by radiation—no great surprise
since FAK is not a generic inhibitor of
apoptosis such as that induced by DNA
damage. On the other hand, functional
FAK does ameliorate the more delayed
apoptosis that attends the actual regener-
ative process, perhaps by blunting the
transient anoikis that inevitably accom-
panies the regenerative remodeling. Pro-
liferation of injured FAK-deficient intestine
is also compromised, suggesting an
additional role for FAK in orchestrating
regenerative cell proliferation. Activated
FAK engages several signaling modali-
ties, including the canonical Ras-Erk,
PLCg, and PI-3K/Akt/mTOR pathways,
so it is potentially intriguing that that
FAK deletion blocks activation of mTOR
during intestinal regeneration and that, in
turn, pharmacological inhibition of either
PI-3K or mTOR blocks radiation-induced
intestinal regeneration. However, such
inferences are less than watertight
because PI-3K/Akt/mTOR signaling is
generically involved in suppressing apo-
ptosis: hence, it is not unexpected that
pharmacological inhibition of this crucial
pathway degrades intestinal regenerative
potential. Similarly, while Ashton et al.’s
restoration of regenerative capacity in
the intestines of FAK-deficient intestines
by systemic administration of IGF-1 is
intriguing, activation of the IGF type I
receptor engages a plenitude of down-ª2010 Elsevier Inc.stream effector pathways, making this
observation provocative but not yet
compelling. That notwithstanding, Ashton
et al. (2010) craft a convincing and
elegantly comprehensive picture of a
fascinating and unexpected regenerative
program that offers new opportunities
for the treatment of a dreadful disease.
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